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Abstract
Background: Patient decision aids (PtDAs) help people make difficult, values-sensitive decisions. Prenatal screening
for assessing the risk of genetic conditions in the fetus is one such decision and patient decision aids are rarely
used in this clinical context. We sought to identify factors influencing pregnant women’s use of a patient decision
aid for deciding about prenatal screening for Down syndrome (DS).
Methods: This qualitative study was embedded in a sequential mixed-methods research program whose main
aim is to implement shared decision-making (SDM) in the context of prenatal screening for DS in the province
of Quebec, Canada. We planned to recruit a purposive sample of 45 pregnant women with low-risk pregnancy
consulting for prenatal care at three clinical sites. Participating women watched a video depicting a prenatal care
follow-up during which a pregnant woman, her partner and a health professional used a PtDA to decide about
prenatal screening for DS. The women were then interviewed about factors that would influence the use of this
PtDA using questions based on the Theoretical Domains Framework (TDF). We performed content analysis of
transcribed verbatim interviews.
Results: Out of 216 eligible women, 100 agreed to participate (46% response rate) and 46 were interviewed.
Regarding the type of health professional responsible for their prenatal care, 19 participants (41%) reported
having made a decision about prenatal screening for DS with an obstetrician-gynecologist, 13 (28%) with a
midwife, 12 (26%) with a family physician, and two (4%) decided on their own. We identified 54 factors that were
mapped onto nine of the 12 TDF domains. The three most frequently-mentioned were: opinion of the pregnant
woman’s partner (n = 33, 72%), presentation of the PtDA by health professional and a discussion (n = 27, 72%),
and not having encountered a PtDA (n = 26, 57%).
Conclusion: This study allowed us to identify factors influencing pregnant women’s use of a PtDA for prenatal
screening for DS. Use of a PtDA by health professionals and patients is one step in providing the needed decision
support and our study results will allow us to design an effective implementation strategy for PtDAs for prenatal
screening for DS.
Keywords: Prenatal testing, Trisomy 21, Down syndrome, Decision aid, Shared decision making, Theoretical
domains framework, Implementation, Knowledge translation
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Background
Health-related decisions can be difficult when they entail
multiple options that may involve risk, loss, regret, or
challenges to personal life values [1, 2]. Whether or not
to undergo prenatal screening to assess the risk of certain
genetic conditions in the fetus, screening which has been
offered for several years in most developed countries, is
one of these difficult decisions [3]. Deciding about pre-
natal screening requires effective decision support if the
decision reached is to be informed and congruent with
what a pregnant woman and her partner value most [4, 5].
Consequently, it is important that health professionals
provide information about screening options and their
risks and potential benefits. It is also necessary to help fu-
ture parents reflect about the implications of living with a
child with a genetic condition, and the implications of ter-
minating the pregnancy. This decision context is thus
value-laden and highly charged [6], and a significant num-
ber of pregnant women experience a less-than-satisfying
decision-making process [7]. These women are conse-
quently at higher risk of decision regret [6].
Studies indicate that most pregnant women want to be
engaged in the decision-making process about prenatal
screening [8, 9]. This can be achieved with patient deci-
sion aids (PtDA), tools that help engage patients in the
decision-making process [10, 11]. These tools allow people
to clarify the decision point, improve their knowledge
about the options that are available, increase their accur-
acy of risk perception, and clarify what is most important
to them as well as communicate it to their health profes-
sional [11–13]. A systematic review of 115 trials of PtDAs
has shown that these tools are effective for assisting the
decision-making process among patients facing difficult
decisions and improve decision outcomes [13]. Therefore,
their potential contribution to decision-making about pre-
natal screening for Down syndrome (DS) is extremely
valuable [14].
In recent years, a number of health organizations across
diverse jurisdictions have embarked on the dissemination
of PtDAs to foster patient engagement in health-related
decisions [15]. However, notwithstanding the positive im-
pacts of PtDA on patient decision-making processes and
decision quality [13], their implementation in routine clin-
ical practice is not the norm [16, 17]. Implementation
strategies need to be devised to foster the use of PtDAs by
pregnant women facing the routine but difficult decision
about prenatal screening [18]. Consequently, we sought to
identify factors influencing pregnant women’s use of a
PtDA for prenatal screening for DS.
Methods
Study design and context
This study was embedded in a sequential mixed-methods
research program whose main aim was to implement
shared decision-making (SDM) in the context of prenatal
screening for DS in the province of Quebec, Canada.
Ethics approval was obtained from the research ethics
boards of the Centre de Santé et de Services Sociaux de
la Vieille-Capitale (#2013-2014-29) in Quebec, and the
CHU de Quebec (#B14-02-1929).
Participants and recruitment procedures
Prenatal care in Canada is offered by family physicians
(53% of pregnancies), obstetricians/gynaecologists (45%)
and midwives (2%) [19]. We wanted to maximize the
diversity of perspectives by drawing from clinical sites
representing different clienteles and different team
approaches to prenatal care. Each kind of health pro-
fessional practises differently, according to studies, and
has different patient loads [20]. The different types of
facility also reflect women’s differing preferences, for
example birthing centers tend to attract clients who
prioritize continuity of care with a midwife, while
people consulting obstetricians/gynecologists prioritize
availability of specialists at all times [21]. Different fa-
cilities may also reflect women’s income status [22].
We thus aimed to recruit a purposive sample of 45
pregnant women split equally between three health
centers in the Quebec City region, Canada: a birthing
center (services provided by midwives), a family medi-
cine site (FMS) (services provided by family physicians)
and a university hospital (services provided by obstetri-
cians/gynecologists). A sample of at least 15 individuals
per subgroup is needed to reach data saturation in this
study type [12, 23].
Women were eligible if they were: a) 18 years or older;
b) in their second trimester of pregnancy; c) had booked
a prenatal follow-up appointment in one of the three
participating health centers; d) the pregnancy was not
categorized as high-risk. So that our study would not in-
fluence their decision, participating women were met by
a research assistant (RA) after they had made a decision
about whether or not to do prenatal screening and were
invited to reflect on a hypothetical decision in case of a
future pregnancy.
The project coordinator and a RA first met with health
professionals from the three participating health centers
during a professional meeting to explain the study process
and to secure their collaboration. The administrative staff
of the centers made accessible their agenda for follow-up
appointments for pregnant women for every recruitment
day; this enabled us to identify potentially eligible partici-
pants. Afterwards, four experienced RA approached po-
tentially eligible pregnant women in the waiting room
before their prenatal appointment. They briefly explained
the project, explained that data would be anonymous and
confidential, and confirmed their eligibility before inviting
them to participate.
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Data collection
To conduct the interviews, we met participating women
either at their homes or at the health center, depending
on their preference. Before beginning the interview, par-
ticipants watched a single 10-min video showing a simu-
lated prenatal care follow-up and were reminded that
the decision point was about using a PtDA or not using
it; and not on making a decision to do the test or not.
The participants were not given the PtDA, but saw the
PtDA on the video, which showed page-by-page shots as
the healthcare professional went through it. All the in-
formation provided by the healthcare professional was
contained in the PtDA and participants were thus in a
position to judge the nature and quantity of the informa-
tion in the PtDA.
The video shows two consecutive consultations be-
tween a health professional, a pregnant women and her
partner. In the first visit, the health professional gives a
PtDA to the couple, explains it to them and invites them
to review it at home. The health professional clarifies
that the pregnant woman is facing a decision to undergo
prenatal screening for DS and explains that more infor-
mation can be found in the PtDA to support their
decision-making process. In a second meeting, without
the PtDA, the couple and health professional come to a
shared decision after the health professional checks that
the couple have understood the pros and cons and have
thought about what is most important for them. The
two consultations reflect the idea that looking at a PtDA
alone is not sufficient: time is needed to digest the infor-
mation. However, the video ends before a choice is made
so that participants would not be influenced by a specific
choice during the interview. Immediately after the video,
we conducted 30-min semi-structured interviews con-
sisting of eleven open-ended questions based on the
Theoretical Domains Framework (TDF).
The TDF is comprised of 12 theoretical domains rele-
vant to behavioral change [24–26]. The 12 theoretical
domains synthesize 33 behavior change theories and
their multiple specific constructs. The TDF postulates
that factors influencing behavior change can be mapped
onto these theoretical domains and can be used to de-
sign effective theory-based implementation interven-
tions. Underlying these factors are salient beliefs that are
amenable to change and can therefore influence behav-
ior change. The 11 interview questions were derived
from nine of the 12 theoretical domains that were most
relevant to the behavior of interest (see Table 1): 1)
knowledge; 2) social/professional role and identity; 3)
beliefs about capabilities; 4) beliefs about consequences;
5) motivation and goals; 6) memory, attention, and deci-
sion processes; 7) environmental context and resources;
8) social influences; and 9) emotions. The three
remaining theoretical domains, behavioral regulation
(e.g. habits), nature of the behavior (e.g. repetitive or
not) and skills (e.g. training for acquiring new skills)
were felt to be less relevant to our behavior of interest
and targeted participants [27, 28], who were pregnant
Table 1 Questionnaire based on the Theoretical Domains constructs (translated from the original French)
Theoretical Domains Constructs Questions
1. Beliefs About Consequences
2. Memory, Attention and
Decision Processes
Advantages What do you think are the advantages of using a Patient Decision Aid in the context of
prenatal screening for Down Syndrome?
Disadvantages What do you think are the disadvantages of using a Patient Decision Aid in the context of
prenatal screening for Down Syndrome?
Anticipated regret How would you feel if you decided not to use a Patient Decision Aid in the context of prenatal
screening for Down Syndrome?
3. Environmental Context
and Resources
Facilitators What would make it easier for you to use of a Patient Decision Aid in the context of prenatal
screening for Down Syndrome?
Barriers What would make it difficult for you to use a Patient Decision Aid in the context of prenatal
screening for Down Syndrome?
4. Social Influences For/approve Who are the people important to you who might encourage you to use a Patient Decision Aid
in the context of prenatal screening for Down Syndrome?
Against/disapprove Who are the people important to you who might discourage you from using a Patient Decision
Aid in the context of prenatal screening for Down Syndrome?
5. Social/Professional Role
and Identity
Descriptive norms What do you think people you know think about using Patient Decision Aids in the context of
prenatal screening for Down Syndrome?
6. Knowledge Up to now, what did you know about Patient Decision Aids in the context of prenatal
screening for Down Syndrome?
7. Emotions In terms of emotions, what would it feel like for you to use a Patient Decision Aid in the
context of prenatal screening for Down Syndrome?
8. Beliefs About Capabilities
9. Motivation and Goals
Incentives What incentives would you need to use a Patient Decision Aid in the context of prenatal
screening for Down Syndrome?
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women facing a decision that is not likely to be repeated
(the fertility rate in the Province of Quebec was 1.62 in
2014) [29]. At the end of the interview, we assessed
participants’ socio-demographic characteristics and ob-
stetrical and gynecological antecedents. Interviews were
audio-recorded and transcribed verbatim. Each record-
ing had an identification code and was uploaded to our
database.
Data analysis
To identify participants’ salient beliefs, the first author
(MELP) analyzed the full transcripts. Using a content
analysis approach, she read each transcript to identify all
the beliefs expressed by each participant. Then, using N-
Vivo v.10 software, similar beliefs were grouped into the-
matic salient beliefs which were than mapped onto the
nine TDF constructs. The number of participants shar-
ing the same salient belief (henceforth referred to as “n”)
and the number of quotes (henceforth referred to as “q”)
referring to each salient belief were calculated. A higher
“q” than “n” value meant that some participants men-
tioned a salient belief more than once. The most fre-
quently elicited salient beliefs in each construct (or
modal beliefs) were identified by dividing the total num-
ber of citations related to this salient belief by the total
number of citations relating to all the salient beliefs
mapped to that construct. Based on this calculation, for
the sake of a future survey (more details in conclusion),
we retained the salient beliefs whose citation frequency
(“q”) represented 75% of the total number of citations,
and all salient beliefs whose citation frequency was at
least 20% for each construct [12]. To validate the coding
scheme, a second researcher (JL) independently read all
the transcripts and double-checked the tree-node. She
suggested the addition of relevant categories or themes
and the removal of less relevant ones, and discussed a
final coding scheme with the second author. Any dis-
crepancies were resolved through discussion with team
members. The same procedure was undertaken with all
identified influential factors.
Results
Participant characteristics
Between July 24, 2014 and January 8, 2015, out of 216
eligible pregnant women, 100 agreed to participate (46%
response rate) (Fig. 1). The most frequently reported
reason for declining was lack of time (see Table 2).
Of those who accepted, we purposively selected a con-
venience sample of 46 participants (15 in each health
center and 16 in the birthing center). Table 3 summa-
rizes participant characteristics. Regarding the type of
health professional responsible for their prenatal care, 19
participants (41%) reported having made a decision
about prenatal screening for DS with an obstetrician-
gynecologist, 13 (28%) with a midwife, 12 (26%) with a
family physician, and two (4%) decided on their own.
Salient beliefs
Additional file 1 presents the 54 distinct salient beliefs
identified across the nine theoretical domain constructs
investigated, with associated quotes. For the sake of our
future survey, modal beliefs (highlighted with an aster-
isk* in Additional file 1) were retained according to the
75% or the 20% principle explained above (see data
analysis section).
Beliefs about consequences
The three most frequently reported advantages of using a
PtDA about prenatal screening for DS were: 1) it helps the
couple reflect later together at home (i.e. helps women de-
cide with their partners) [n = 25(54%); q = 44(27%)], 2) it is
a useful source of information [n = 25(54%); q = 39(24%)],
and 3) it helps make an informed decision [n = 25(54%);
q = 37(23%)]. Only a few participants said the PtDA
allowed them to clarify their personal values [n = 5(11%);
q = 9(6%)]. The most reported disadvantage was that it
could create confusion during the decision-making
process [n = 10(22%); q = 15(88%)].
Fig. 1 Flowchart of participants: pregnant women receiving care
from obstetrician-gynecologists, family physicians or midwives
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Further to the presentation of the PtDA in the video,
some pregnant women [n = 14(30%); q = 18(50%)] said
they might regret not using the PtDA if they knew it
existed, but others said that they would be comfort-
able with the decision not to use it [n = 15(33%); q =
16(44%)].
Memory, attention, and decision processes
The only reported factor was that too much information
was presented (i.e. information overload) [n = 15(33%);
q = 17(100%)].
Environmental context and resources
The two most frequently reported facilitators were: 1) the
PtDA should be handed out and explained by a health
professional [n = 27(59%); q = 39(50%)]; and 2) the PtDA
should be available on a website (for consulting online or
downloading) [n = 16(35%); q = 22(28%)]. A few partici-
pants [n = 3(7%); q = 4(5%)], all of whom were followed by
family physicians, reported that they might use the PtDA
if they didn’t feel forced to use it because of the health
professional’s limited time for follow-up. The two most
frequently reported barriers were: 1) not having it to look
at (i.e. lack of access to the PtDA) [n = 13(28%); q =
14(24%)], and 2) if the health professional’s presentation
of the PtDA was unconvincing and failed to capture their
attention or interest [n = 10(22%); q = 13(22%)].
Social influences
The two most frequently mentioned salient beliefs re-
garding who might encourage participants to use a PtDA
in this context were: 1) pregnant women’s partners [n =
33(72%); q = 33(35%)] and 2) health professionals [n =
20(44%); q = 25(27%)]. The most frequently reported sa-
lient belief regarding who might discourage participants
from using a PtDA was also identified as the partner [n =
8(17%); q = 8(29%)], but the second most frequently re-
ported individual was a friend [n = 7(15%); q = 7(25%)].
Social/Professional role and identity
The salient beliefs regarding this theoretical domain
were: 1) a positive impression (i.e. a good practice that
helps decision-making) [n = 25(54%); q = 29(74%)], 2) no
impression at all because they didn’t know what it was
[n = 8 (17%); q = 8(21%)], and 3) a negative impression
[n = 2(4%); q = 2 (5%)].
Knowledge
Most of the participants mentioned not knowing what
a decision aid was before participating in the project
[n = 26(57%); q = 26(57%)], implying that knowledge of
the existence of the PtDA was a significant factor in-
fluencing its subsequent use. Others said that they
were given an information pamphlet by the govern-
ment screening program [n = 17(37%); q = 17(37%)],
and a smaller number said that they had heard of
PtDAs [n = 3(7%); q = 3(7%)].
Emotions
The two most frequently mentioned salient beliefs re-
garding emotions were: 1) stress induced by knowing
about risks and benefits of the test [n = 21(46%); q =
34(45%)], and 2) fear of knowing the results of the test
[n = 9(20%); q = 11(15%)].
Beliefs about capabilities
The only salient belief mentioned regarding beliefs about
capabilities was that it helps to make a decision (i.e.
increases competency in decision-making) [n = 21(46%);
q = 25(100%)].
Motivation and goals
The two most frequently reported incentives for using a
PtDA for DS prenatal screening were: 1) the need to be
informed [n = 21(46%); q = 24(53%)]; and 2) the presence
of Down syndrome risk factors in one’s family and en-
tourage [n = 6(13%); q = 9(20%)].
Interestingly, we had excluded three theoretical do-
mains from the interview questions (behavioral habits,
repetitiveness of the behavior and behavior skills) be-
cause we felt they were not relevant to the targeted
population and behavior of interest, and in fact the
women interviewed did not of their own accord men-
tion any salient beliefs that mapped onto these three
excluded theoretical domains.
Discussion
We identified factors influencing pregnant women’s use
of a PtDA for prenatal screening for DS. We recruited
eligible pregnant women from three different kinds of
health care center (a family medicine site, a birthing
center and a university hospital) representing diverse
clienteles. A total of 54 salient beliefs were mapped
Table 2 Reasons for declining
Followed by Lack of time Lack of interest Don’t like interviews Others Total
Ob/gyn 44 38 4 2 88
Family physician 6 5 1 0 12
Midwife 7 3 3 3 16
Total 57 46 8 5 116
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Table 3 Sociodemographic characteristics
Characteristics* Followed by Ob/gyn
n = 15
n (%)
Followed by Family physician
n = 15
n (%)
Followed by Midwife
n = 16
n (%)
Total
N = 46
N (%)
Age (mean ± SD) 30 ± 6 31 ± 3 29 ± 4 30 ± 4
< 35 years 12 (80) 14 (93) 15 (94) 41 (89)
> 35 years 3 (20) 1 (7) 1 (6) 5 (11)
Marital status
Single 3 (20) 2 (13) 5 (11)
Married/common law 15 (100) 12 (80) 14 (88) 41 (89)
Employment status
Full time 12 (80) 13 (87) 10 (63) 35 (76)
Part time 1 (7) 4 (25) 5 (11)
Unemployed and seeking work 1 (7) 1 (2)
Unemployed and not seeking work 1 (7) 1 (2)
Other 1 (7)a 1 (7)b 2 (13)a 4 (9)
Level of schooling
Pre-secondary 1 (7) 1 (2)
Graduated from secondary 2 (13) 1 (7) 3 (7)
College without graduation 3 (20) 3 (7)
Graduated from college 2 (13) 1 (7) 1 (6) 4 (9)
University without graduation 1 (7) 1 (7) 1 (6) 3 (7)
Graduated from university 7 (47) 11 (73) 14 (88) 32 (70)
Household size
2 8 (53) 8 (53) 10 (63) 26 (57)
3 4 (27) 6 (40) 5 (31) 15 (33)
4 2 (13) 1 (7) 1 (6) 4 (9)
5 1 (7) 1 (2)
Annual household income
$15 000 to $29 999 2 (13) 1 (6) 3 (7)
$30 000 to $44 999 2 (13) 1 (7) 2 (13) 5 (11)
$45 000 to $59 999 3 (20) 3 (20) 3 (19) 9 (20)
$60 000 or more 9 (60) 9 (60) 10 (63) 28 (61)
Other 1 (7)c 1 (2)
Number of pregnancies
1st pregnancy 6 (40) 8 (53) 8 (50) 22 (48)
2nd pregnancy 4 (27) 6 (40) 6 (38) 16 (35)
3rd or more pregnancy 5 (33) 1 (7) 2 (13) 8 (17)
Health professional with whom the decision was made
Obstetrician/gynecologist 14 (93) 2 (13) 3 (19) 19 (41)
Family physician 12 (80) 12 (26)
Midwife 13 (81) 13 (28)
Made the decision alone 1 (7) 1 (7) 2 (4)
*Percentages may not total 100 due to rounding
aStudent
bSelf-employed
cDon’t know (has only been in Quebec for 4 months)
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onto nine of the 12 domains of the TDF. Of their own
accord, participants did not express any salient belief
that mapped onto the three theoretical domains that
we had excluded. Overall, the three most frequently-
mentioned factors were: 1) influence of the woman’s
partner, 2) presentation of the PtDA by a health profes-
sional and a discussion about it, and 3) lack of know-
ledge about PtDAs. Our results lead us to make four
main observations.
First, as we observed, even if participating women
identified advantages to using a PtDA about prenatal
screening for DS, they also identified disadvantages, sug-
gesting a certain ambivalence overall. On the one hand
they said it provided useful information for decision-
making, but they also said the amount of information
could create confusion during decision-making. As re-
ported in other studies assessing factors influencing the
uptake of innovative tools in clinical practice [18, 30],
we observed that a single factor may be perceived both
as a barrier and a facilitator. In our case, the same factor
(i.e. information giving) can be both positive (i.e. more
information is helpful) and negative (i.e. too much of it is
confusing). Indeed, attitude ambivalence has been shown
to moderate the relationship between social norms and
behaviour [31]. Research directed specifically to reducing
this attitudinal ambivalence regarding information about
prenatal tests could inform the improvement of PtDAs
[32]. The next step would be to quantitatively assess the
relative importance of these two conflicting aspects of the
same influential factor to better devise a population ap-
proach to implementing PtDAs for prenatal screening for
DS. Developers should clearly not overload PtDAs with
information, and implementation strategies should be
more individualized. In addition, in real life, the physician
may not take this much time to go through the PtDA page
by page, but in the second visit, as shown in the video, he/
she would check that the couple understands the infor-
mation and what concerns them most about the options.
Decision aids alone cannot replace patient-physician
interaction [33].
Second, these study results provide a more in-depth
understanding of pregnant women’s opinions regarding
the use of a PtDA for prenatal screening. For example,
although an overwhelming majority of women men-
tioned that the PtDA was useful for obtaining informa-
tion for decision-making, they also shared with us that
knowing this information on the risks and benefits of
the options would most likely increase their stress. This
fear of stressful information has been reported before
[34, 35]. Moreover, individuals tend to be bad fore-
casters: they anticipate either better or worse outcomes
than can be expected based on the evidence [36]. PtDAs
inform patients about potential outcomes of all options,
good and bad, and help individuals better understand
the probabilities associated with potential outcomes.
This prompts patients to reflect then and there on risk,
loss, regret, or the challenges to personal life values
entailed in the decision they are facing. PtDAs raise pa-
tients’ awareness of potential outcomes they may want
to avoid, which may provoke anxiety at the time of
decision-making, but they also ensure that patients have
realistic expectations about their choices [13, 37, 38] and
give them the chance to resolve their personal uncer-
tainties about the decision beforehand. Future imple-
mentation strategies for PtDA should therefore include
managing patients’ perceptions of the anxiety they fear
that using PtDA might cause, and affective support for
the stress if it occurs.
Third, the most frequently reported factor influencing
the use of the PtDA was the woman’s partner, with the
health professional in second place. Both these findings
have been reported before [38, 39]. Most of the women
in this study were in a couple; in addition, the presence
of the partner in the video they watched before the in-
terviews may have disposed some of them to consider
their partner as their most important influence. Perhaps
the use of the PtDA also made the women aware that
the decision was a values-sensitive one, in which case
they would naturally want to discuss it with someone
close to them (partner) or a trustworthy health profes-
sional, and have more information about it. Together
these results highlight the importance of supportive re-
lationships at the personal and professional level when
making difficult health-related decisions and the need
for training in this field [40]. Although promising,
PtDAs alone may not be enough to ensure high quality
decision-making for pregnant women and should be ac-
companied by training of health professionals in shared
decision-making [41]. Future research on interventions
should consider both the partner and the health profes-
sional in the effective implementation of PtDAs about
prenatal screening for DS.
Lastly, even if one of the stated aims of PtDAs is to
help patients clarify and communicate the personal
values they associate with the available options [42], only
a small number of participants said that the PtDA could
help them identify what is most important for them and
thus help them make the decision that best meets their
values and their preferences. Other studies [43, 44] show
that in the context of prenatal screening, one of the eth-
ical principles is personal autonomy framed in terms of
women’s choice [44], so it was surprising that only a few
women mentioned the PtDA could help them clarify
personal values. Further studies should emphasize the
relevance of identifying and expressing personal values
as a basis for good decision-making.
This study has a few limitations. First, the character-
istics of our sample population do not represent all
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pregnant women across the sociodemographic spectrum.
Women eligible for this study were highly educated and
at low risk of complications or of carrying a fetus with
DS (they were mostly younger than 35 years old). Al-
though we made sure to recruit women from diverse
clinical contexts, we observed few differences between
sites. Second, at times it was difficult to keep to the
main subject of the interview because participants fo-
cused on the behavior of undertaking the prenatal test
rather than the behavior of using a PtDA to decide
about the test, which was the behavior of interest of
this study. This may have affected the results of our
study. However, our experienced interviewers were able
to redirect the conversation to the studied behavior and
avoid information bias.
Third, as we mentioned, during the analysis a second
researcher checked the first researcher’s tree-node. It
may have been preferable for her to independently de-
velop her own tree-node first. Nevertheless, we consider
that what is most important is a systematic and thor-
ough coding process, whether the coding is carried out
by a single conscientious researcher or by a whole team
of coders [45].
Lastly, although we were aiming to understand the
factors influencing pregnant women’s use of a PtDA for
prenatal screening for DS along the whole prenatal care
pathway (i.e. during health professional visits, at home
with family members or friends, and on their own), the
video may have triggered only those beliefs associated
with use of the PtDA during a consultation with a
health professional. However, we made sure that the
video included two visits with the health professional
and also that participants understood they could use
the PtDA outside the consultation, as was also recom-
mended by the health professional in the video.
Conclusion
This study allowed us to identify factors influencing
pregnant women’s use of a PtDA for prenatal screening
for DS. Prenatal screening decisions are difficult and
pregnant women need decision support to make this
values-based decision. Use of a PtDA by health profes-
sionals and patients is one step in providing the
needed decision support and our study results will
allow us to design an effective implementation strategy
for PtDA for prenatal screening for DS. Our next step
is to translate these salient beliefs into closed-ended
questions to conduct a cross-sectional survey that will
allow us to determine the relative importance of these
beliefs and thus refine our implementation strategy.
Ultimately, our goal is to ensure that all pregnant
women have useful decision support tools to help them
make informed values-based decisions regarding pre-
natal screening for DS.
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